NRXS
AMEX:NRXS
NeurAxis, Inc.
- Stock
Last Close
3.12
26/07 19:58
Market Cap
20.74M
Beta: -
Volume Today
1.47K
Avg: 14.56K
PE Ratio
−0.87
PFCF: −2.71
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|
average inventory | 73.01K - | 43.66K 40.21% | 34.68K 20.57% | ||
average payables | 324.17K - | 1.04M 220.18% | 1.40M 34.70% | ||
average receivables | 213.31K - | 144.85K 32.10% | 123.78K 14.54% | ||
book value per share | 0.64 - | -0.32 150.23% | -0.91 181.74% | ||
capex per share | -0.01 - | -0.00 94.99% | -0.01 1,737.74% | ||
capex to depreciation | -0.77 - | -0.04 95.11% | -1.65 4,252.84% | -1.76 6.94% | |
capex to operating cash flow | 0.01 - | 0.00 90.71% | 0.03 4,181.22% | 0.01 59.74% | |
capex to revenue | -0.01 - | -0.00 96.44% | -0.02 4,363.18% | -0.03 27.99% | |
cash per share | 0.74 - | 0.13 83.07% | 0.04 67.00% | ||
days of inventory on hand | 81.06 - | 30.58 62.28% | 59.14 93.40% | 25.53 56.83% | |
days payables outstanding | 124.85 - | 377.59 202.44% | 1.96K 418.08% | 1.45K 25.93% | |
days sales outstanding | 58.87 - | 15.47 73.73% | 23.71 53.31% | 10.86 54.21% | |
debt to assets | 0.41 - | 2.09 407.78% | 0.40 80.61% | 0.44 8.83% | |
debt to equity | 0.70 - | -1.92 375.59% | -0.11 94.41% | -0.16 48.75% | |
dividend yield | |||||
earnings yield | -146.12K - | -118.74K 18.74% | -0.13 100.00% | ||
enterprise value | -1.58M - | 118.44K 107.48% | 37.01M 31,143.57% | 145.70K 99.61% | |
enterprise value over ebitda | 0.44 - | -0.04 109.15% | -6.56 16,250.74% | -0.02 99.66% | |
ev to operating cash flow | 0.38 - | -0.05 113.85% | -16.10 30,277.80% | -0.02 99.86% | |
ev to sales | -0.82 - | 0.04 105.30% | 13.78 31,568.93% | 0.06 99.57% | |
free cash flow per share | -1.63 - | -0.88 46.35% | -0.39 55.96% | ||
free cash flow yield | -163.41K - | -87.67K 46.35% | -0.06 100.00% | ||
graham net net | 0.41 - | -0.45 211.83% | -1.09 139.27% | ||
graham number | 4.60 - | 2.94 36.11% | 4.01 36.24% | ||
income quality | 1.11 - | 0.74 33.58% | 0.48 34.85% | 0.46 4.80% | |
intangibles to total assets | 0.01 - | 0.03 239.32% | 0.05 66.28% | 0.21 304.95% | |
interest coverage | -54.43 - | -80.43 47.77% | -8.08 89.96% | -1.24 84.60% | |
interest debt per share | 0.15 - | 0.19 22.99% | 0.17 10.92% | ||
inventory turnover | 4.50 - | 11.94 165.09% | 6.17 48.29% | 14.30 131.63% | |
invested capital | 0.19 - | -0.53 380.75% | -0.11 79.81% | -0.16 48.75% | |
market cap | 25.50 - | 25.50 0% | 36.66M 143,760,071.10% | ||
net current asset value | 1.32M - | -1.10M 183.21% | -6.58M 500.59% | -1.67M 74.61% | |
net debt to ebitda | 0.44 - | -0.04 109.15% | -0.06 52.52% | -0.02 64.01% | |
net income per share | -1.46 - | -1.19 18.74% | -0.78 34.12% | ||
operating cash flow per share | -1.62 - | -0.88 46.02% | -0.38 57.07% | ||
payables turnover | 2.92 - | 0.97 66.94% | 0.19 80.70% | 0.25 35.01% | |
receivables turnover | 6.20 - | 23.60 280.67% | 15.39 34.77% | 33.62 118.41% | |
research and ddevelopement to revenue | 0.09 - | 0.07 13.50% | 0.08 12.42% | 0.07 18.10% | |
return on tangible assets | -1.35 - | -4.11 204.93% | -3.41 17.13% | -36.44 969.53% | |
revenue per share | 0.76 - | 1.07 40.98% | 0.44 58.82% | ||
roe | -2.27 - | 3.67 261.78% | 0.86 76.61% | 10.42 1,115.39% | |
roic | 3.53 - | 8.14 130.22% | 0.76 90.72% | 7.73 922.65% | |
sales general and administrative to revenue | 2.53 - | 1.68 33.68% | 1.91 13.78% | 3.39 77.40% | |
shareholders equity per share | 0.64 - | -0.32 150.23% | -0.91 181.74% | ||
stock based compensation to revenue | 0.03 - | 0.02 29.26% | 0.01 43.07% | ||
tangible asset value | 1.62M - | -849.62K 152.52% | -5.65M 565.14% | -1.51M 73.26% | |
tangible book value per share | 0.64 - | -0.32 150.23% | -0.92 185.66% | ||
working capital | 1.45M - | -933.85K 164.26% | -6.50M 596.16% | -1.64M 74.73% |
All numbers in USD (except ratios and percentages)